Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Emergent BioSolutions Inc (NYSE: EBS) fell significantly of late. EBS’ current Value Trend Rating is C and the prior Rating was A. Details supporting this lower rating are included in our next report.
Recent Price Action
Emergent BioSolutions Inc (NYSE: EBS) stock closed at $5.77 on 3/7/25 after a modest decline of -1.2%. However, below average trading volume at 78% of normal accompanied the decline. The stock has declined -18.3% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Emergent BioSolutions has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Emergent BioSolutions has a good Appreciation Score of 77 but a neutral Power Rating of 43, producing the High Neutral Value Trend Rating.
Be the first to comment